EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

CT83 Promotes Cancer Progression by Upregulation of PDL1 in Adenocarcinoma of the Cervix

Gilhyang Kim iD, Kyung-Jun Lee, Eun Shin, Sung Taek Park iD, Hyeong Su Kim, Hye-Yon Cho iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26062687 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Gilhyang Kim und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Kangnam Sacred-Heart Hospital, Hallym University Medical Center, Hallym University College of Medicine, Seoul 07441, Republi…. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, B7-H1 Antigen, Adenocarcinoma, Antigens, Neoplasm. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hallym University Dongtan Sacred Heart Hospital, Hallym University Research Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

CT83, a cancer-testis antigen, has emerged as a potential biomarker and therapeutic target in various cancers. This study explores its expression and role in cervical adenocarcinoma progression and prognosis. CT83 expression was analyzed in cervical cancer cell lines using quantitative PCR and Western blotting. Functional assays demonstrated that CT83 overexpression (OE) promotes proliferation, migration, invasion, and epithelial–mesenchymal transition (EMT) in cervical cancer cells while also upregulating PD-L1 expression. Conversely, CT83 knockdown reduced these malignant phenotypes. The immunohistochemical analysis of 60 patient samples revealed CT83 expression in 84.9% of cases, with significant correlations to larger tumor size, elevated squamous cell carcinoma antigen (SCC) levels, and advanced FIGO stages (II–IV). Furthermore, intermediate-to-high CT83 expression (H-score ≥100) was associated with more aggressive disease features. These findings suggest that CT83 contributes to tumor progression and immune evasion, likely through PD-L1 modulation. As a highly expressed antigen in cervical adenocarcinoma, CT83 offers promise as a diagnostic marker and therapeutic target for improving patient outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uterine Cervical NeoplasmsB7-H1 AntigenAdenocarcinomaAntigens, NeoplasmHumansFemaleDisease ProgressionMiddle AgedGene Expression Regulation, NeoplasticCell Line, TumorUp-RegulationCell ProliferationEpithelial-Mesenchymal TransitionCell MovementBiomarkers, TumorAdultPrognosisAgedWAP Four-Disulfide Core Domain Protein 2

Stichwörter der Autor:innen

CT83PDL1adenocarcinomacervix cancer

Substanzen

B7-H1 AntigenCD274 protein, humanAntigens, NeoplasmBiomarkers, TumorWFDC2 protein, humanWAP Four-Disulfide Core Domain Protein 2

Autor:innen und Institutionen

  • Department of Pathology, Kangnam Sacred-Heart Hospital, Hallym University Medical Center, Hallym University College of Medicine, Seoul 07441, Republic of Korea.
  • Department of Pathology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul 03181, Republic of Korea.
  • Institute of New Frontier Research Team, Hallym University, Chuncheon 24252, Republic of Korea.
  • Department of Pathology, Dongtan Sacred-Heart Hospital, Hallym University Medical Center, Hallym University College of Medicine, Kyeonggido 18450, Republic of Korea.
  • Department of Obstetrics and Gynecology, Kangnam Sacred-Heart Hospital, Hallym University Medical Center, Hallym University College of Medicine, Seoul 07441, Republic of Korea.
  • Department of Internal Medicine, Kangnam Sacred-Heart Hospital, Hallym University College of Medicine, Seoul 07441, Republic of Korea.

ORCID-Profile: Gilhyang Kim, Sung Taek Park, Hye-Yon Cho

Förderung

  • Hallym University Dongtan Sacred Heart Hospital
  • Hallym University Research Fund

Zitieren

APA

Kim, G., Lee, K. J., Shin, E., Park, S. T., Kim, H. S., & Cho, H. Y. (2025). CT83 Promotes Cancer Progression by Upregulation of PDL1 in Adenocarcinoma of the Cervix. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26062687

Vancouver

Kim G, Lee KJ, Shin E, Park ST, Kim HS, Cho HY. CT83 Promotes Cancer Progression by Upregulation of PDL1 in Adenocarcinoma of the Cervix. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26062687

BibTeX
@article{Kim2025,
  author = {Kim, Gilhyang and Lee, Kyung-Jun and Shin, Eun and Park, Sung Taek and Kim, Hyeong Su and Cho, Hye-Yon},
  title = {CT83 Promotes Cancer Progression by Upregulation of PDL1 in Adenocarcinoma of the Cervix},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26062687}
}
Kostenlos starten →